Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Clinical trial NCT00765947 · COMPLETED

Trial details

NCT number: NCT00765947
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension ( Mild to Moderate)

Start date: 2008-09-01
Primary completion: 2009-08-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.